BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28949844)

  • 1. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.
    Jamal L; Robinson JO; Christensen KD; Blumenthal-Barby J; Slashinski MJ; Perry DL; Vassy JL; Wycliff J; Green RC; McGuire AL
    AJOB Empir Bioeth; 2017; 8(2):82-88. PubMed ID: 28949844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
    Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
    J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gratitude, protective buffering, and cognitive dissonance: How families respond to pediatric whole exome sequencing in the absence of actionable results.
    Werner-Lin A; Zaspel L; Carlson M; Mueller R; Walser SA; Desai R; Bernhardt BA
    Am J Med Genet A; 2018 Mar; 176(3):578-588. PubMed ID: 29446570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.
    Vassy JL; Lautenbach DM; McLaughlin HM; Kong SW; Christensen KD; Krier J; Kohane IS; Feuerman LZ; Blumenthal-Barby J; Roberts JS; Lehmann LS; Ho CY; Ubel PA; MacRae CA; Seidman CE; Murray MF; McGuire AL; Rehm HL; Green RC;
    Trials; 2014 Mar; 15():85. PubMed ID: 24645908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project.
    Roberts JS; Robinson JO; Diamond PM; Bharadwaj A; Christensen KD; Lee KB; Green RC; McGuire AL;
    Genet Med; 2018 Sep; 20(9):1069-1076. PubMed ID: 29300387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public attitudes in Japan toward participation in whole genome sequencing studies.
    Okita T; Ohashi N; Kabata D; Shintani A; Kato K
    Hum Genomics; 2018 Apr; 12(1):21. PubMed ID: 29653595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for the provision of whole genome sequencing services among young adults.
    Wade CH; Elliott KR
    PLoS One; 2017; 12(3):e0174131. PubMed ID: 28334023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient perspectives on whole-genome sequencing for undiagnosed diseases.
    Boeldt DL; Cheung C; Ariniello L; Darst BF; Topol S; Schork NJ; Philis-Tsimikas A; Torkamani A; Fortmann AL; Bloss CS
    Per Med; 2017 Jan; 14(1):17-25. PubMed ID: 29749824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared decision making: Implications for return of results from whole-exome and whole-genome sequencing.
    Vadaparampil ST; Cragun D
    Transl Behav Med; 2018 Jan; 8(1):80-84. PubMed ID: 29385585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
    Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
    Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues.
    Hallowell N; Hall A; Alberg C; Zimmern R
    J Med Ethics; 2015 Apr; 41(4):317-21. PubMed ID: 25038088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine.
    Marshall DA; Gonzalez JM; MacDonald KV; Johnson FR
    Value Health; 2017 Jan; 20(1):32-39. PubMed ID: 28212966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivations, concerns and preferences of personal genome sequencing research participants: Baseline findings from the HealthSeq project.
    Sanderson SC; Linderman MD; Suckiel SA; Diaz GA; Zinberg RE; Ferryman K; Wasserstein M; Kasarskis A; Schadt EE
    Eur J Hum Genet; 2016 Jan; 24(1):14-20. PubMed ID: 26036856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counselors' views and experiences with the clinical integration of genome sequencing.
    Machini K; Douglas J; Braxton A; Tsipis J; Kramer K
    J Genet Couns; 2014 Aug; 23(4):496-505. PubMed ID: 24671342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "We don't know her history, her background": adoptive parents' perspectives on whole genome sequencing results.
    Crouch J; Yu JH; Shankar AG; Tabor HK
    J Genet Couns; 2015 Feb; 24(1):67-77. PubMed ID: 25011977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.
    Christensen KD; Vassy JL; Phillips KA; Blout CL; Azzariti DR; Lu CY; Robinson JO; Lee K; Douglas MP; Yeh JM; Machini K; Stout NK; Rehm HL; McGuire AL; Green RC; Dukhovny D;
    Genet Med; 2018 Dec; 20(12):1544-1553. PubMed ID: 29565423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing.
    Yu JH; Harrell TM; Jamal SM; Tabor HK; Bamshad MJ
    Am J Hum Genet; 2014 Jul; 95(1):77-84. PubMed ID: 24975944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing.
    Robinson JO; Carroll TM; Feuerman LZ; Perry DL; Hoffman-Andrews L; Walsh RC; Christensen KD; Green RC; McGuire AL;
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):21-30. PubMed ID: 26928896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.